Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non‐small cell lung cancer patients

por Shiono, Ayako, Kaira, Kyoichi, Mouri, Atsuto, Yamaguchi, Ou, Hashimoto, Kosuke, Uchida, Takahiro, Miura, Yu, Nishihara, Fuyumi, Murayama, Yoshitake, Kobayashi, Kunihiko, Kagamu, Hiroshi
Publicado 2019

Peripheral blood telomere alterations in ground glass opacity (GGO) lesions may suggest malignancy

por Koslow, Matthew, Shitrit, David, Israeli‐Shani, Lilach, Uziel, Orit, Beery, Einat, Osadchy, Alexandra, Refaely, Yael, Shochet, Gali Epstein, Amiel, Aliza
Publicado 2019

Malignant pleural effusion as a predictor of the efficacy of anti‐PD‐1 antibody in patients with non‐small cell lung cancer

por Shibaki, Ryota, Murakami, Shuji, Shinno, Yuki, Matsumoto, Yuji, Goto, Yasushi, Kanda, Shintaro, Horinouchi, Hidehito, Fujiwara, Yutaka, Motoi, Noriko, Yamamoto, Noboru, Ohe, Yuichiro
Publicado 2019

Analysis of factors related to chronic cough after lung cancer surgery

por Xie, Ming‐ran, Zhu, Yong‐fu, Zhou, Mei‐qi, Wu, Sheng‐bing, Xu, Guang‐wen, Xu, Shi‐bin, Xu, Mei‐qing
Publicado 2019

Chemotherapy combined with Endostar as salvage treatment for EGFR‐tyrosine kinase inhibitor primary resistance in an advanced non‐small cell lung cancer patient with EGFR L858R mut...

por Qiu, Dong, Zhang, Yu, Xue, Ying‐bo, Shen, Qi, Li, Hang, Huang, Ping, Hu, Jian‐jun, Wang, Yong‐sheng
Publicado 2019

Re‐biopsy and liquid biopsy for patients with non‐small cell lung cancer after EGFR‐tyrosine kinase inhibitor failure

por Zhou, Juan, Zhao, Chao, Zhao, Jing, Wang, Qi, Chu, Xiangling, Li, Jiayu, Zhou, Fei, Ren, Shengxiang, Li, Xuefei, Su, Chunxia, Zhou, Caicun
Publicado 2019

Lung cancer imaging methods in China from 2005 to 2014: A national, multicenter study

por Hou, Dong‐Hui, Zhao, Shi‐Jun, Shi, Ju‐Fang, Wang, Le, Wang, De‐Bin, Huang, Yun‐Chao, Liao, Xian‐Zhen, Xing, Xiao‐Jing, Du, Ling‐Bin, Yang, Li, Liu, Yu‐Qin, Zhang, Yong‐Zhen, Wei, Dong‐Hua, Liu, Yun‐Yong, Zhang, Kai, Li, Ni, Chen, Wan‐Qing, Qiao, You‐Lin, He, Jie, Dai, Min, Wu, Ning
Publicado 2019

Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab

por Yamaguchi, Ou, Kaira, Kyoichi, Hashimoto, Kosuke, Mouri, Atsuto, Miura, Yu, Shiono, Ayako, Nishihara, Fuyumi, Murayama, Yoshitake, Noda, Shin‐ei, Kato, Shingo, Kobayashi, Kunihiko, Kagamu, Hiroshi
Publicado 2019

Mitochondrial NDUFA4L2 protein promotes the vitality of lung cancer cells by repressing oxidative stress

por Meng, Lifei, Yang, Xuhui, Xie, Xiao, Wang, Mingsong
Publicado 2019

Larger tumors are associated with inferior progression‐free survival of first‐line EGFR‐tyrosine kinase inhibitors and a lower abundance of EGFR mutation in patients with advanced...

por Pan, Yingying, Gao, Guanghui, Chen, Xiaoxia, Tian, Qinrui, Wu, Fengying, Liu, Qian, Wang, Yan, Jiang, Tao, Liu, Yiwei, Li, Xuefei, Yang, Shuo, Xu, Chuan, Su, Chunxia, Zhou, Fei, Ren, Shengxiang, Zhou, Caicun
Publicado 2019

Annexin 1–nuclear factor‐κB–microRNA‐26a regulatory pathway in the metastasis of non‐small cell lung cancer

por Guan, Xiaoying, Fang, Ying, Long, Jie, Zhang, Yajie
Publicado 2019

Metabolic gene NR4A1 as a potential therapeutic target for non‐smoking female non‐small cell lung cancer patients

por Sun, Rong, Bao, Min‐Yue, Long, Xin, Yuan, Yuan, Wu, Miao‐Miao, Li, Xin, Bao, Jin‐Ku
Publicado 2019

Comparative efficacy and safety of first‐line treatments for advanced non‐small cell lung cancer with immune checkpoint inhibitors: A systematic review and meta‐analysis

por Chen, Rui, Hou, Xiaoming, Yang, Liping, Zhao, Da
Publicado 2019

Systemic immune‐inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non‐small cell lung cancer

por Guo, Wei, Cai, Songhua, Zhang, Fan, Shao, Fei, Zhang, Guochao, Zhou, Yang, Zhao, Liang, Tan, Fengwei, Gao, Shugeng, He, Jie
Publicado 2019

Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population‐based analysis

por Yang, Qiao, Xu, Zihan, Chen, Xiewan, Zheng, Linpeng, Yu, Yongxin, Zhao, Xianlan, Chen, Mingjing, Luo, Bangyu, Wang, Jianmin, Sun, Jianguo
Publicado 2019

Fluorine‐18‐fluorodeoxyglucose‐positron emission tomography evaluation in metastatic bone lesions in lung cancer: Possible prediction of pain and skeletal‐related events

por Gomi, Daisuke, Fukushima, Toshirou, Kobayashi, Takashi, Sekiguchi, Nodoka, Koizumi, Tomonobu, Oguchi, Kazuhiko
Publicado 2019

Clinical and computed tomography characteristics of non‐small cell lung cancer with ALK gene rearrangement: Comparison with EGFR mutation and ALK/EGFR‐negative lung cancer

por Mori, Mio, Hayashi, Hideyuki, Fukuda, Minoru, Honda, Sumihisa, Kitazaki, Takeshi, Shigematsu, Kazuto, Matsuyama, Naohiro, Otsubo, Mayumi, Nagayasu, Takeshi, Hashisako, Mikiko, Tabata, Kazuhiro, Uetani, Masataka, Ashizawa, Kazuto
Publicado 2019

Association between tooth loss and upper gastrointestinal cancer: A 30‐year follow‐up of the Linxian Dysplasia Nutrition Intervention Trial Cohort

por Zhang, Su, Yu, Pei, Wang, Jian‐Bing, Fan, Jin‐Hu, Qiao, You‐Lin, Taylor, Philip R.
Publicado 2019

Intensity of SLX predicts distance of tumor spread through alveolar spaces in stage I lung adenocarcinoma

por Hara, Kantaro, Mizuguchi, Shinjiro, Okada, Satoshi, Izumi, Nobuhiro, Tsukioka, Takuma, Komatsu, Hiroaki, Ohsawa, Masahiko, Inaba, Mayumi, Shibata, Toshihiko, Nishiyama, Noritoshi
Publicado 2019

Mixed response to osimertinib and the beneficial effects of additional local therapy

por Shinno, Yuki, Goto, Yasushi, Sato, Jun, Morita, Ryo, Matsumoto, Yuji, Murakami, Shuji, Kanda, Shintaro, Horinouchi, Hidehito, Fujiwara, Yutaka, Yamamoto, Noboru, Ohe, Yuichiro
Publicado 2019